Jim Robinson

Jim Robinson is a co-founder of A2 Biotherapeutics, Inc., a company operating in the biotechnology research sector. A2 Biotherapeutics, Inc. cREATING THE FUTURE OF PRECISION CELL THERAPIES. Based in Agoura Hills, California, United States, Jim leads the company's strategic vision and day-to-day operations.

Under Jim's leadership, A2 Biotherapeutics, Inc. recently secured $80M in Series C funding on Jan 10, 2025, backed by investors including The Column Group. This funding milestone reflects strong investor confidence in both the founding team's execution capabilities and the company's market opportunity.

With fresh capital, Jim and the team are focused on scaling operations, expanding the product roadmap, and building out a world-class team. The biotechnology research market continues to see significant investment activity, positioning A2 Biotherapeutics, Inc. to capitalize on growing demand.For vendors and partners, this represents an ideal window to engage.